PHILADELPHIA — Brian L. Strom, MD, MPH, has been appointed to the role of Executive Vice Dean for Institutional Affairs, at Penn Medicine. The appointment, made by J. Larry Jameson, MD, PhD, Executive Vice President of the University of Pennsylvania Health System and Dean of the University of Pennsylvania's Perelman School of Medicine, will take effect on March 1, 2012.
In his new role, Strom will assume the responsibilities of coordinating Penn Medicine's efforts in comparative effectiveness research, as well as the Neuroscience of Behavior Initiative, which seeks to strengthen Penn's programs in basic, translational, clinical, and population research in the areas of addiction, depressive disorders, and neurodegenerative disease. In consultation with Dean Jameson, Strom will also provide administrative leadership for the recruitment of department chairs, center and institute directors, and other senior faculty members. Along with other members of Penn
Medicine leadership, he will also assist with implementing recommendations that emerge from the School's current strategic planning process.
"Over more than three decades, Brian has made enormous contributions to the success of Penn Medicine," Jameson said. "He began his career at Penn as an assistant professor in 1980, rising through the ranks of the faculty while also holding positions of increasing administrative responsibility. I have enormous respect for his skills, judgment, and temperament and am delighted that he will be expanding his role on behalf of Penn Medicine."
Since 2007 Strom has served as vice dean for institutional affairs, with primary responsibilities as Penn Medicine's liaison to the Philadelphia Veteran's Administration Medical Center and Penn's global health programs in Guatemala and Peru. He will continue to serve the Perelman School of Medicine in these areas.
Strom is the founding chair of the Department of Biostatistics and Epidemiology and the founding director of the Center for Clinical Epidemiology and Biostatistics at Penn Medicine. As the George S. Pepper Professor of Public Health and Preventive Medicine, he has served as chair and center director since 1995. Author of more than 550 papers and principal investigator of more than 250 grants, he is an elected member of the Institute of Medicine of the National Academy of Sciences and one of the few clinical epidemiologists elected to the American Society of Clinical Investigation and American Association of Physicians. He is renowned for his work in the field of pharmacoepidemiology, and serves as editor-in-chief for Pharmacoepidemiology and Drug Safety, the official journal of the International Society for Pharmacoepidemiology.
Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $5.3 billion enterprise.
The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 18 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $373 million awarded in the 2015 fiscal year.
The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center -- which are recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report -- Chester County Hospital; Lancaster General Health; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2015, Penn Medicine provided $253.3 million to benefit our community.